Cargando…

What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern

Detalles Bibliográficos
Autores principales:	Gauckler, Philipp, Bettac, Erica L, Nairz, Manfred, Duftner, Christina, Luger, Anna K, Stein, Markus, Wanner, David, Böckle, Barbara C, Tiefenthaler, Martin, Schratzberger, Peter, Neuwirt, Hannes, Harasser, Lukas, Mayer, Gert, Kronbichler, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053319/ https://www.ncbi.nlm.nih.gov/pubmed/33262111 http://dx.doi.org/10.1136/annrheumdis-2020-219212

Ejemplares similares

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA Status or Clinical Phenotype — What Counts More?
por: Windpessl, Martin, et al.
Publicado: (2021)

Risk factors for serious infections in ANCA-associated vasculitis
por: Odler, Balazs, et al.
Publicado: (2023)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma—A case report
por: Gauckler, Philipp, et al.
Publicado: (2020)

ANCA Vasculitis Induction Management During the COVID-19 Pandemic
por: Salas, Antonio, et al.
Publicado: (2021)

Nasal microbiome research in ANCA-associated vasculitis: Strengths, limitations, and future directions
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Challenges of defining renal response in ANCA-associated vasculitis: call to action?
por: Odler, Balazs, et al.
Publicado: (2023)

Eosinophilia and Kidney Disease: More than Just an Incidental Finding?
por: Gauckler, Philipp, et al.
Publicado: (2018)

Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study
por: Kronbichler, Andreas
Publicado: (2013)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab
por: Bruchfeld, Annette, et al.
Publicado: (2021)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

In Reply to ‘Do SGLT-2 Inhibitors Act Only Through a Functional Tubuloglomerular Feedback Induced by the Increased Outflow of Sodium?’
por: Neuwirt, Hannes, et al.
Publicado: (2020)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Animal Models of ANCA Associated Vasculitis
por: Shochet, Lani, et al.
Publicado: (2020)

Eye involvement in ANCA positive vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2020)

Mechanisms of thrombosis in ANCA-associated vasculitis
por: Misra, Durga Prasanna, et al.
Publicado: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
por: Müller, Antje, et al.
Publicado: (2021)

Complement Inhibition in ANCA-Associated Vasculitis
por: Tesar, Vladimir, et al.
Publicado: (2022)

The involvement of NETs in ANCA-associated vasculitis
por: Shiratori-Aso, Satoka, et al.
Publicado: (2023)

Pathophysiology of ANCA-Associated Small Vessel Vasculitis
por: Kallenberg, Cees G. M.
Publicado: (2010)

Ocular disease in patients with ANCA-positive vasculitis
por: Watkins, Angela S., et al.
Publicado: (2009)

Levamisole-Induced ANCA Vasculitis and Cutaneous Necrosis
por: Tichauer, Matthew, et al.
Publicado: (2014)

Familial clusters of ANCA small-vessel vasculitis
por: Gomes, Ana Marta, et al.
Publicado: (2009)

Interstitial Lung Disease with ANCA-associated Vasculitis
por: Katsumata, Yasuhiro, et al.
Publicado: (2015)

Neutrophil Extracellular Traps in ANCA-Associated Vasculitis
por: Söderberg, Daniel, et al.
Publicado: (2016)

ANCA-associated vasculitis in childhood: recent advances
por: Calatroni, Marta, et al.
Publicado: (2017)

FIBROTIC PROTEASE 3 ANCA-ASSOCIATED VASCULITIS
por: Megri, Mohammed, et al.
Publicado: (2020)

Therapy of ocular complications in ANCA+ associated vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2021)

ANCA-associated vasculitis after COVID-19
por: Izci Duran, Tugba, et al.
Publicado: (2021)

B Lineage Cells in ANCA-Associated Vasculitis
por: Merino-Vico, Ana, et al.
Publicado: (2021)

ANCA Associated Vasculitis Subtypes: Response [Letter]
por: Merkel, Peter A, et al.
Publicado: (2022)

Manifestations of Covid-19-associated ANCA-vasculitis
por: Lishchuk-Yakymovych, Khrystyna, et al.
Publicado: (2023)

Daratumumab for the treatment of refractory ANCA-associated vasculitis
por: Ostendorf, Lennard, et al.
Publicado: (2023)

Vitamin D status in ANCA-associated vasculitis
por: Doubelt, Irena, et al.
Publicado: (2023)

Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis
por: Knütter, Ilka, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_54c0895mvla653lec2vs313g28